Free Trial

MoonLake Immunotherapeutics (MLTX) SEC Filings & 10K Form

MoonLake Immunotherapeutics logo
$39.84 +1.45 (+3.78%)
Closing price 03/27/2025 04:00 PM Eastern
Extended Trading
$39.84 -0.01 (-0.01%)
As of 03/27/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent MoonLake Immunotherapeutics SEC Filings

DateFilerForm TypeView
03/03/2025
8:06 PM
Bodenstedt Matthias (Reporting)
MoonLake Immunotherapeutics (Issuer)
MoonLake Immunotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
8:07 PM
MoonLake Immunotherapeutics (Issuer)
MoonLake Immunotherapeutics (Issuer)
Reich Kristian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
8:08 PM
MoonLake Immunotherapeutics (Issuer)
MoonLake Immunotherapeutics (Issuer)
Santos da Silva Jorge (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
6:09 AM
MoonLake Immunotherapeutics (Filer)
MoonLake Immunotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2025
6:13 AM
MoonLake Immunotherapeutics (Filer)
MoonLake Immunotherapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2025
8:44 AM
MoonLake Immunotherapeutics (Subject)
MoonLake Immunotherapeutics (Subject)
Form SCHEDULE 13G
02/12/2025
8:30 AM
FMR LLC (Filed by)
MoonLake Immunotherapeutics (Subject)
MoonLake Immunotherapeutics (Subject)
Form SCHEDULE 13G/A
01/22/2025
8:55 PM
MoonLake Immunotherapeutics (Issuer)
MoonLake Immunotherapeutics (Issuer)
Reich Kristian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
3:30 PM
MoonLake Immunotherapeutics (Filer)
MoonLake Immunotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
6:03 AM
MoonLake Immunotherapeutics (Filer)
MoonLake Immunotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
6:05 AM
MoonLake Immunotherapeutics (Filer)
MoonLake Immunotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/08/2024
5:48 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
MoonLake Immunotherapeutics (Subject)
MoonLake Immunotherapeutics (Subject)
Form SC 13D/A
10/08/2024
5:50 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
LAMPERT MARK N (Reporting)
MoonLake Immunotherapeutics (Issuer)
MoonLake Immunotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
6:30 AM
MoonLake Immunotherapeutics (Filer)
MoonLake Immunotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
7:02 AM
MoonLake Immunotherapeutics (Filer)
MoonLake Immunotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
7:04 AM
MoonLake Immunotherapeutics (Filer)
MoonLake Immunotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/10/2024
4:06 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
LAMPERT MARK N (Reporting)
MoonLake Immunotherapeutics (Issuer)
MoonLake Immunotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:40 PM
MoonLake Immunotherapeutics (Filer)
MoonLake Immunotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2024
6:30 AM
MoonLake Immunotherapeutics (Filer)
MoonLake Immunotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
7:01 AM
MoonLake Immunotherapeutics (Filer)
MoonLake Immunotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
7:02 AM
MoonLake Immunotherapeutics (Filer)
MoonLake Immunotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2024
6:57 AM
MoonLake Immunotherapeutics (Filer)
MoonLake Immunotherapeutics (Filer)
Form 10-K/A
04/24/2024
3:30 PM
MoonLake Immunotherapeutics (Filer)
MoonLake Immunotherapeutics (Filer)
Form DEF 14A
04/24/2024
3:31 PM
MoonLake Immunotherapeutics (Filer)
MoonLake Immunotherapeutics (Filer)
Form DEFA14A
04/24/2024
3:33 PM
MoonLake Immunotherapeutics (Filer)
MoonLake Immunotherapeutics (Filer)
Form ARS
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:MLTX) was last updated on 3/28/2025 by MarketBeat.com Staff
From Our Partners